120 related articles for article (PubMed ID: 23085340)
1. A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats.
Pałucha-Poniewiera A; Pilc A
Behav Brain Res; 2013 Feb; 238():109-12. PubMed ID: 23085340
[TBL] [Abstract][Full Text] [Related]
2. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
Summa M; Di Prisco S; Grilli M; Usai C; Marchi M; Pittaluga A
Neuropharmacology; 2013 Mar; 66():215-24. PubMed ID: 22564442
[TBL] [Abstract][Full Text] [Related]
4. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.
Palucha A; Klak K; Branski P; van der Putten H; Flor PJ; Pilc A
Psychopharmacology (Berl); 2007 Nov; 194(4):555-62. PubMed ID: 17622518
[TBL] [Abstract][Full Text] [Related]
5. The effects of mGlu₇ receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains.
O'Connor RM; Cryan JF
Behav Pharmacol; 2013 Apr; 24(2):105-13. PubMed ID: 23455446
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.
Hikichi H; Murai T; Okuda S; Maehara S; Satow A; Ise S; Nishino M; Suzuki G; Takehana H; Hata M; Ohta H
Eur J Pharmacol; 2010 Aug; 639(1-3):106-14. PubMed ID: 20371227
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats.
Bahi A; Fizia K; Dietz M; Gasparini F; Flor PJ
Addict Biol; 2012 Mar; 17(2):235-47. PubMed ID: 21392179
[TBL] [Abstract][Full Text] [Related]
9. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
[TBL] [Abstract][Full Text] [Related]
10. Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning.
Klakotskaia D; Ramsey AK; Fowler SW; Serfozo P; Simonyi A; Schachtman TR
Behav Brain Res; 2013 Sep; 253():9-16. PubMed ID: 23827202
[TBL] [Abstract][Full Text] [Related]
11. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
Podkowa K; Pilc A; Podkowa A; Sałat K; Marciniak M; Pałucha-Poniewiera A
Neuropharmacology; 2018 Oct; 141():214-222. PubMed ID: 30145321
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
Domin H; Jantas D; Śmiałowska M
Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
[TBL] [Abstract][Full Text] [Related]
13. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.
Bradley SR; Uslaner JM; Flick RB; Lee A; Groover KM; Hutson PH
Pharmacol Biochem Behav; 2012 Mar; 101(1):35-40. PubMed ID: 22138407
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
Greco B; Lopez S; van der Putten H; Flor PJ; Amalric M
J Pharmacol Exp Ther; 2010 Mar; 332(3):1064-71. PubMed ID: 19940105
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
Suzuki G; Tsukamoto N; Fushiki H; Kawagishi A; Nakamura M; Kurihara H; Mitsuya M; Ohkubo M; Ohta H
J Pharmacol Exp Ther; 2007 Oct; 323(1):147-56. PubMed ID: 17609420
[TBL] [Abstract][Full Text] [Related]
16. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway.
Wang WY; Wang H; Luo Y; Jia LJ; Zhao JN; Zhang HH; Ma ZW; Xue QS; Yu BW
Neuroscience; 2012 Mar; 205():167-77. PubMed ID: 22244976
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal.
Wang CC; Kuo JR; Huang SK; Wang SJ
Eur J Pharmacol; 2018 Mar; 823():11-18. PubMed ID: 29378190
[TBL] [Abstract][Full Text] [Related]
18. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
[TBL] [Abstract][Full Text] [Related]
19. The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?
Sukoff Rizzo SJ; Leonard SK; Gilbert A; Dollings P; Smith DL; Zhang MY; Di L; Platt BJ; Neal S; Dwyer JM; Bender CN; Zhang J; Lock T; Kowal D; Kramer A; Randall A; Huselton C; Vishwanathan K; Tse SY; Butera J; Ring RH; Rosenzweig-Lipson S; Hughes ZA; Dunlop J
J Pharmacol Exp Ther; 2011 Jul; 338(1):345-52. PubMed ID: 21508084
[TBL] [Abstract][Full Text] [Related]
20. Impact of the metabotropic glutamate receptor7 (mGlu
Kotlinska JH; Lopatynska-Mazurek M; Gawel K; Gabka P; Jenda-Wojtanowska M; Kruk-Slomka M; Marszalek-Grabska M; Danilczuk Z; Kedzierska E; Talarek S; Listos J; Gibula-Tarlowska E
Eur J Pharmacol; 2019 Sep; 858():172512. PubMed ID: 31260653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
